Who is sponsoring NCT02637492?

NCT02637492 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT02637492?

Interventions in NCT02637492: Collection of clinical signs and symptoms.

What condition does NCT02637492 study?

NCT02637492 studies Lower Limb Ischaemia.

Is NCT02637492 still recruiting?

NCT02637492 is currently completed. Last updated 14 March 2022.

Last reviewed 2022-03-14 · How we verify

NCT02637492: PREDICCMI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development and Validation of a Clinical Prediction Rule for Lower Limb Critical Limb Ischaemia (PREDICCMI)

Completed Last updated 14 March 2022

What this trial tests

trial testing Collection of clinical signs and symptoms in Lower Limb Ischaemia in 603 participants. Completed in 1 February 2022.

Timeline

15 February 2016

Primary endpoint
4 February 2021

1 February 2022

Quick facts

Lead sponsor	University Hospital, Bordeaux
Status	Completed
Study type	OBSERVATIONAL
Enrollment	603
Start date	15 February 2016
Primary completion	4 February 2021
Estimated completion	1 February 2022
Sites	3 locations across France

Drugs / interventions tested

Collection of clinical signs and symptoms

Conditions studied

Lower Limb Ischaemia — all drugs for Lower Limb Ischaemia →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Lower Limb Ischaemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Critical limb ischaemia (CLI) is the most serious stage of peripheral occlusive arterial disease (POAD). Despite progress in the revascularization procedures, half these patients experience amputation or death after one year. One issue is to identify these subjects because aggressive treatment is necessary in those cases, while in others (ie leg ulcer in a patient with POAD but no rest lower limb ischaemia), revascularization will not be necessary. Then it would be useful to develop a simple score to help the physician to improve diagnosis of CLI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02637492 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 14 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02637492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing